Author: fletchercsi

By Tina Witte, SVP of Life Sciences    The energy, excitement, and deal volumes at this year’s JPM Morgan Healthcare conference always set the tone for what is to come in the year ahead. Outside of the big pharma M&A and announcements, there is much to discern on what is happening in the innovative biotech READ MORE

Since the launch of Chat GPT – the ground- breaking artificial intelligence tool, companies based in the United States appeared to have had a huge head start in the development of the most significant technology of this generation. This was compounded at the start of the year by a new & radical U.S government announcing the ambitious stated intent of investing billions of dollars in the race for AI supremacy. READ MORE

In thinking about how dynamic and rapidly evolving global healthcare is, having sound innovation and resilience strategies will be paramount to navigating these shifting landscapes. READ MORE

Outside of all of the buzz of AI in healthcare, the next prominent topic in 2024 centered around the increasing scrutiny and negotiation of drug prices by governments worldwide. This trend is largely driven by the need to make medications more affordable and accessible, amidst rising healthcare costs and economic pressures.   READ MORE

CI/MI professionals ignore US Presidential elections at their peril, and the recently concluded 2024 election is no exception. CI/MI professionals know that the outcome of a US Presidential election impacts overall competitive market conditions. READ MORE

If you ask ChatGPT or Gemini what makes great CI/MI, you will get a range of answers, mostly focused on data collection. However, great competitive intelligence is about more than just delivering information. READ MORE

It was another exciting 2024 Pharma CI USA assembly! For our 17th year in attendance, Fletcher continued its role as a key legacy sponsor and session presenter. This year’s topic: Are Disruptors Disrupting Your Strategy?, was a walkthrough of some of the most significant industry disruptors and ways CI/MI practitioners better predict, adjust, and enhance strategies to stay competitive. READ MORE

The summer 2024 Olympic Games were a joy to experience. Watching elite athletes at the zenith of sport compete highlighted the hard work it takes to excel and the importance of strategic and competitive insights. Referees and judges leveraged the latest technologies to ensure athletes had a level playing field. READ MORE

Despite the known challenges and limitations inherent to biotech, this surge has propelled the industry onto a positive growth trajectory. Each transaction, big or small, holds the capacity to reshape the healthcare landscape, prompting frequent reviews and updates to strategic outlooks. READ MORE

Every year in Q1, the Consumer Analyst Group NY (CAGNY) hosts a weeklong conference where leading CPGs share current performance metrics and strategies for the year’s balance in hopes of winning investors’ confidence and wallets. READ MORE